Skip to the page

Data / Drug companies / Baxter Healthcare Corporation

Baxter Healthcare Corporation: 273 products in the FDA NDC directory, labeler code 0338

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Baxter Healthcare Corporation (labeler code 0338) lists 273 products in the FDA National Drug Code Directory, covering 58 finished drugs by generic name. By type: 261 prescription drugs, 12 plasma derivatives. Its main marketing category is new drug applications (NDA). The newest product started marketing on October 19, 2026.

The request: Watch Baxter Healthcare Corporation (FDA labeler code 0338): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
0338
Products in commercial distribution
273
Packages
341
Finished drugs by generic name
58
Prescription products
261
Over the counter products
0
Flagged as original packager
229 of 229 products that carry the flag
Started marketing in the last 12 months
4
Earliest marketing start
November 14, 1958
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
New drug applications (NDA)21478.4%
Generic drugs (ANDA)3111.4%
Biologics (BLA)165.9%
Unapproved drugs for a shortage103.7%
Authorized generics (NDA)20.7%

Products by type

TypeProductsShare
Prescription drugs26195.6%
Plasma derivatives124.4%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Sodium chloride3571
Dextrose monohydrate2612
Fibrinogen human, human thrombin121
Vancomycin hydrochloride839
Potassium chloride, dextrose monohydrate and sodium chloride81
Clindamycin phosphate831
Norepinephrine bitartrate625
Gentamicin sulfate520
Doxorubicin hydrochloride520
Heparin sodium423
I.v. fat emulsion43
Daptomycin in sodium chloride41
Dextrose and sodium chloride42
Magnesium sulfate heptahydrate420
Water440
Epinephrine332
Nitroglycerin340
Cefazolin sodium35
Thrombin topical recombinant31
Dobutamine hydrochloride32
Piperacillin sodium and tazobactam sodium35
Micafungin in sodium chloride31
Pantoprazole sodium in 0.9% sodium chloride31
Potassium chloride384
Dopamine hydrochloride310
Potassium chloride and sodium chloride31
Doxorubicin hydrochloride liposome21
Lidocaine hydrochloride2134
Ifosfamide25
Cyclophosphamide injection, solution21
Penicillin g21
Mesna29
Mannitol29
Metronidazole268
Ketorolac tromethamine269
Fluconazole248
Ceftriaxone sodium212
Vasopressin in 0.9% sodium chloride21
Dexmedetomidine hydrochloride221
Milrinone lactate212
I. v. fat emulsion11
Sodium bicarbonate151
Olive oil and soybean oil11
Trisodium citrate dihydrate14
Acetic acid17
Oxacillin15
Sodium chloride, calcium chloride, potassium chloride,11
Famotidine1138
Eptifibatide19
Glycine13
Cefepime16
Magnesium sulfate in dextrose12
Fosaprepitant dimeglumine112
Nafcillin15
Insulin human14
Sorbitol12
Cysteine hydrochloride12
Potassium chloride and dextrose monohydrate11

Dosage forms

Dosage formProductsShare
Injection, solution13649.8%
Injection8832.2%
Irrigant145.1%
Solution103.7%
Kit93.3%
Injection, suspension, liposomal72.6%
Emulsion51.8%
Injection, powder, for solution20.7%
Injection, emulsion10.4%
Injection, powder, lyophilized, for solution10.4%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Epinephrine0338-0010Injection, solutionNew drug applications (NDA)October 19, 2026
Sodium bicarbonate0338-0822Injection, solutionNew drug applications (NDA)August 14, 2026
Epinephrine0338-0006Injection, solutionNew drug applications (NDA)March 16, 2026
Magnesium Sulfate0338-6353Injection, solutionGeneric drugs (ANDA)January 8, 2026
Epinephrine0338-0024Injection, solutionNew drug applications (NDA)February 28, 2025
Sodium Chloride0338-9834IrrigantUnapproved drugs for a shortageDecember 3, 2024
Sodium Chloride0338-0110IrrigantUnapproved drugs for a shortageNovember 13, 2024
Plasma-Lyte 148 (pH 7.4)0338-9593Injection, solutionUnapproved drugs for a shortageNovember 8, 2024
Sodium Chloride0338-9808Injection, solutionUnapproved drugs for a shortageOctober 21, 2024
Sodium Chloride0338-9793Injection, solutionUnapproved drugs for a shortageOctober 21, 2024
Sodium Chloride0338-9791Injection, solutionUnapproved drugs for a shortageOctober 21, 2024
Sodium Chloride0338-9810Injection, solutionUnapproved drugs for a shortageOctober 18, 2024
Sodium Chloride0338-9806Injection, solutionUnapproved drugs for a shortageOctober 18, 2024
Sodium Chloride0338-9804Injection, solutionUnapproved drugs for a shortageOctober 18, 2024
Doxil0338-9667Injection, suspension, liposomalNew drug applications (NDA)August 26, 2024
Doxil0338-9665Injection, suspension, liposomalNew drug applications (NDA)August 26, 2024
Cyclophosphamide0338-9779InjectionNew drug applications (NDA)August 1, 2024
Cyclophosphamide0338-9777InjectionNew drug applications (NDA)August 1, 2024
Clinimix e0338-7036InjectionNew drug applications (NDA)July 15, 2024
Clinimix e0338-7034InjectionNew drug applications (NDA)July 15, 2024
Clinimix e0338-7032InjectionNew drug applications (NDA)July 15, 2024
Clinimix e0338-7030InjectionNew drug applications (NDA)July 15, 2024
Clinimix e0338-7028InjectionNew drug applications (NDA)July 15, 2024
Clinimix e0338-7026InjectionNew drug applications (NDA)July 15, 2024
Clinimix e0338-7024InjectionNew drug applications (NDA)July 15, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.